Bionano genomics to present at the 2022 h.c. wainwright global investment conference

San diego, may 17, 2022 (globe newswire) -- bionano genomics, inc. (bngo), pioneer of optical genome mapping (ogm) solutions on the saphyr® system and provider of nxclinical™ software, the leading solution for visualization, interpretation and reporting of genomic data, today announced its virtual participation in the 2022 h.c. wainwright global investment conference. erik holmlin, phd, bionano's president and chief executive officer, will present a company overview available for on-demand listening starting tuesday, may 24, 2022, at 7:00 a.m. eastern time. interested parties can register for the conference and view the presentation here: www.hcwevents.com/globalconference.
BNGO Ratings Summary
BNGO Quant Ranking